Jim Young

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Antiretroviral Therapy

Hiv Infected Patients

Placebo Controlled

Top Venues

Patient preference and adherence

International journal of epidemiology

Pharmacology research & perspectives

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Daniela K van Santen, Ashleigh Stewart, Joseph S Doyle, Mark A Stoové, Jason Asselin, Marina B Klein, Jim Young, Juan Berenguer, Inmaculada Jarrin, Karine Lacombe, Linda Wittkop, Olivier Leleux, Dominique Salmon, Fabrice Bonnet, Andri Rauch, Catrina Mugglin, Gail Matthews, Maria Prins, Colette Smit, Anders Boyd, Marc van der Valk, Rachel Sacks-Davis, Margaret E Hellard, null null
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC). International journal of epidemiology (2023)
Marina B Klein, Jim Young, David Ortiz-Paredes, Shouao Wang, Sharon Walmsley, Alexander Wong, Valérie Martel-Laferrière, Neora Pick, Brian Conway, Jonathan Angel, Jean-Guy Baril, Chris Fraser, Bertrand Lebouché, Darrell Hoi-San Tan, Roger Sandre, Sylvie Trottier, Hansi Peiris, Jayamarx Jayaraman, Joel Singer, null null
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286). Patient preference and adherence 16 (2022)
Marina B Klein, Jim Young, David Ortiz-Paredes, Shouao Wang, Sharon Walmsley, Alexander Wong, Valérie Martel-Laferrière, Neora Pick, Brian Conway, Jonathan Angel, Jean-Guy Baril, Chris Fraser, Bertrand Lebouché, Darrell Hoi-San Tan, Roger Sandre, Sylvie Trottier, Hansi Peiris, Jayamarx Jayaraman, Joel Singer, null null
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286). Patient preference and adherence 16 (2022)
Jim Young, Stanley Wong, Naveed Z Janjua, Marina B Klein
Comparing direct acting antivirals for hepatitis C using observational data - Why and how? Pharmacology research & perspectives 8 (5) (2021)
Jim Young, Vincent Lo Re, H Nina Kim, Timothy R Sterling, Keri N Althoff, Kelly A Gebo, M John Gill, Michael A Horberg, Angel M Mayor, Richard D Moore, Michael J Silverberg, Marina B Klein, null null
Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design. Pharmacoepidemiology and drug safety (2021)